Elizabeth Tan-Chiu
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies 15
- Oncology top 0.2%
- HER2/EGFR in Cancer Research 21
- Cancer Treatment and Pharmacology 13
- Genetics top 0.2%
- Estrogen and related hormone effects 8
- Pathology and Forensic Medicine top 0.5%
- Breast Lesions and Carcinomas 7
-
- Monoclonal and Polyclonal Antibodies Research 9
-
- Advanced Breast Cancer Therapies 12
-
- PI3K/AKT/mTOR signaling in cancer 4
- Co-authors
- Norman WolmarkBernard FisherD. Lawrence WickerhamJoseph P. CostantinoVictor G. VogelMaureen KavanahJames N. AtkinsWalter M. Cronin
- Cited by
- Cancer ResearchOncologyGenetics
- Journals
- Journal of Clinical Oncology (19 papers)JNCI Journal of the National Cancer Institute (7 papers)Biochemistry (1 paper)
- Partner nations
- United StatesBelgiumSpain
In The Last Decade
Elizabeth Tan-Chiu
47 papers receiving 8.4k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 3.2k
- Oncology 5.2k
- Genetics 3.2k
- Pathology and Forensic Medicine 1.4k
- Radiology, Nuclear Medicine and Imaging 1.5k
Countries citing papers authored by Elizabeth Tan-Chiu
This map shows the geographic impact of Elizabeth Tan-Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Tan-Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Tan-Chiu more than expected).
Fields of papers citing papers by Elizabeth Tan-Chiu
This network shows the impact of papers produced by Elizabeth Tan-Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Tan-Chiu. The network helps show where Elizabeth Tan-Chiu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elizabeth Tan-Chiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 12 | |
| 2 | 2018 | 50 | |
| 3 | 2017 | 13 | |
| 4 | 2016 | 0 | |
| 5 | 2013 | 58 | |
| 6 | 2011 | 283 | |
| 7 | 2009 | 136 | |
| 8 | 2007 | 1 | |
| 9 | 2006 | 236 | |
| 10 | Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31breakdown → | 2005 | 568 |
| 11 | 2004 | 27 | |
| 12 | 2004 | 79 | |
| 13 | 2003 | 61 | |
| 14 | 2002 | 375 | |
| 15 | 2001 | 113 | |
| 16 | 2001 | 110 | |
| 17 | 1999 | 380 | |
| 18 | Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Studybreakdown → | 1998 | 4021 |
| 19 | erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancerbreakdown → | 1998 | 515 |
| 20 | 1995 | 16 |
About Elizabeth Tan-Chiu
Elizabeth Tan-Chiu is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 48 papers that have together received 8.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (21 papers), Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (13 papers), Advanced Breast Cancer Therapies (12 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Estrogen and related hormone effects (8 papers), Breast Lesions and Carcinomas (7 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Cancer Research (3.2k citations), Oncology (5.2k citations) and Genetics (3.2k citations). Elizabeth Tan-Chiu has collaborated with scholars based in United States, Belgium and Spain. Frequent co-authors include Norman Wolmark, Bernard Fisher, D. Lawrence Wickerham, Joseph P. Costantino, Victor G. Vogel, Maureen Kavanah, James N. Atkins, Walter M. Cronin, André Robidoux and Carol Redmond. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.